A Xenopus type I activin receptor mediates mesodermal but not neural specification during embryogenesis

Area of Science:

• Developmental Biology
• Molecular Signaling
• Embryogenesis

Background:

• Activins and TGFbeta superfamily ligands utilize heteromeric receptor complexes for signaling.
• Disruption of type II activin receptor (XActRIIB) signaling in Xenopus embryos inhibits mesoderm induction and promotes neuralization.

Purpose of the Study:

• To clone and characterize a type I activin receptor, XALK4, in Xenopus.
• To investigate the roles of XALK4 and its truncated mutant (tXALK4) in embryonic development.
• To compare the signaling functions of type I (XALK4) and type II (XActRIIB) activin receptors.

Main Methods:

• Cloning and characterization of the XALK4 receptor.
• In vitro and in vivo experiments using truncated and active forms of XALK4.
• Analysis of mesoderm induction, neuralization, and BMP4-mediated epidermal specification in Xenopus embryos.

Main Results:

• A truncated XALK4 mutant (tXALK4) inhibits mesoderm formation in vitro and in vivo.
• An active form of XALK4 induces mesoderm independently of ligands.
• Unlike truncated XActRIIB, tXALK4 does not promote neuralization and does not inhibit BMP4-mediated epidermal specification.

Conclusions:

• Type I (XALK4) and type II (XActRIIB) activin receptors are involved in overlapping yet distinct embryonic signaling events.
• XALK4 plays a crucial role in mesoderm formation, while XActRIIB regulates both mesoderm and ectoderm specification.
• Differential effects on BMP4 signaling explain the distinct roles of type I and type II activin receptors.